Coulthard KP - Search Results

1

Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis--caution with trough concentrations.

Coulthard KP, Peckham DG, Conway SP, Smith CA, Bell J, Turnidge J. Coulthard KP, et al. J Cyst Fibros. 2007 Apr;6(2):125-30. doi: 10.1016/j.jcf.2006.05.015. Epub 2006 Jul 7. J Cyst Fibros. 2007. PMID: 16829216 Free article.

2

What is the best method for measuring renal function in adults and children with cystic fibrosis?

Soulsby N, Greville H, Coulthard K, Doecke C. Soulsby N, et al. J Cyst Fibros. 2010 Mar;9(2):124-9. doi: 10.1016/j.jcf.2009.12.002. Epub 2010 Feb 4. J Cyst Fibros. 2010. PMID: 20133211

3

Renal dysfunction in cystic fibrosis: is there cause for concern?

Soulsby N, Greville H, Coulthard K, Doecke C. Soulsby N, et al. Pediatr Pulmonol. 2009 Oct;44(10):947-53. doi: 10.1002/ppul.21086. Pediatr Pulmonol. 2009. PMID: 19728391 Review.

4

Use of neutrophil gelatinase-associated lipocalin (NGAL) in CF.

Munro C, Ranganathan S, Coulthard K, Quinlan C. Munro C, et al. J Cyst Fibros. 2015 Jan;14(1):154. doi: 10.1016/j.jcf.2014.06.010. Epub 2014 Jul 10. J Cyst Fibros. 2015. PMID: 25016967 No abstract available.

5

Determination of tobramycin in saliva is not suitable for therapeutic drug monitoring of patients with cystic fibrosis.

Madsen V, Lind A, Rasmussen M, Coulthard K. Madsen V, et al. J Cyst Fibros. 2004 Dec;3(4):249-51. doi: 10.1016/j.jcf.2004.08.003. Epub 2004 Oct 27. J Cyst Fibros. 2004. PMID: 15698943

6

Subacute toxicity of colistin methanesulfonate in rats: comparison of various intravenous dosage regimens.

Wallace SJ, Li J, Nation RL, Rayner CR, Taylor D, Middleton D, Milne RW, Coulthard K, Turnidge JD. Wallace SJ, et al. Antimicrob Agents Chemother. 2008 Mar;52(3):1159-61. doi: 10.1128/AAC.01101-07. Epub 2008 Jan 7. Antimicrob Agents Chemother. 2008. PMID: 18180359 Free PMC article.

7

Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model.

Bergen PJ, Li J, Nation RL, Turnidge JD, Coulthard K, Milne RW. Bergen PJ, et al. J Antimicrob Chemother. 2008 Mar;61(3):636-42. doi: 10.1093/jac/dkm511. Epub 2008 Jan 28. J Antimicrob Chemother. 2008. PMID: 18227094

8

Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate.

Li J, Milne RW, Nation RL, Turnidge JD, Smeaton TC, Coulthard K. Li J, et al. J Antimicrob Chemother. 2004 May;53(5):837-40. doi: 10.1093/jac/dkh167. Epub 2004 Mar 24. J Antimicrob Chemother. 2004. PMID: 15044428

9

Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis.

Li J, Coulthard K, Milne R, Nation RL, Conway S, Peckham D, Etherington C, Turnidge J. Li J, et al. J Antimicrob Chemother. 2003 Dec;52(6):987-92. doi: 10.1093/jac/dkg468. Epub 2003 Oct 29. J Antimicrob Chemother. 2003. PMID: 14585859

10

Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration.

Li J, Milne RW, Nation RL, Turnidge JD, Smeaton TC, Coulthard K. Li J, et al. Antimicrob Agents Chemother. 2003 May;47(5):1766-70. doi: 10.1128/aac.47.5.1766-1770.2003. Antimicrob Agents Chemother. 2003. PMID: 12709357 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results